Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB

Oncogene. 2006 Sep 21;25(42):5708-18. doi: 10.1038/sj.onc.1209579. Epub 2006 May 8.


Overexpression of cyclooxygenase-2 (Cox-2) is thought to exert antiapoptotic effects in cancer. Here we show that the tumor suppressor p53 upregulated Cox-2 in esophageal and colon cancer cell lines by inducing the binding of nuclear factor-kappaB (NF-kappaB) to its response element in the COX-2 promoter. Inhibition of NF-kappaB prevented p53 induction of Cox-2 expression. Cooperation between p53 and NF-kappaB was required for activation of COX-2 promoter in response to daunomycin, a DNA-damaging agent. Pharmacological inhibition of Cox-2 enhanced apoptosis in response to daunomycin, in particular in cells containing active p53. In esophageal cancer, there was a correlation between Cox-2 expression and wild-type TP53 in Barrett's esophagus (BE) and in adenocarcinoma, but not in squamous cell carcinoma (P<0.01). These results suggest that p53 and NF-kappaB cooperate in upregulating Cox-2 expression, promoting cell survival in inflammatory precursor lesions such as BE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caspases / metabolism
  • Cell Division
  • Cell Line, Tumor
  • Cyclooxygenase 2 / metabolism*
  • DNA Primers
  • Dinoprostone / metabolism
  • Enzyme Activation
  • Gene Expression Regulation, Enzymologic
  • Genes, p53*
  • Humans
  • Kinetics
  • NF-kappa B / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcriptional Activation*


  • DNA Primers
  • NF-kappa B
  • Cyclooxygenase 2
  • Caspases
  • Dinoprostone